A hearing has been scheduled for March 1 in a legal case brought by a whistleblower who confirmed that violations occurred during the Pfizer–BioNTech COVID-19 vaccine clinical trial.
Ventavia, a subcontractor for Pfizer’s COVID-19 vaccine Phase 3 clinical trial, failed to properly report adverse events and keep all participants blinded, according to internal communications revealed by Brook Jackson, the whistleblower. Ventavia and other companies were hired by ICON, a clinical research group that was paid by Pfizer, to run trial sites.
